Videos
Sharp Clinical Services Moves to New $23M Facility
Sharp Clinical Services Moves to New $23M Facility
Adds 1.5 million cubic feet of clinical services capacity on a 14-acre site; increases pallet space for cold and controlled-temperature storage by 50%
01.24.19
Sharp Clinical Services, a part of UDG Healthcare, and a provider of contract packaging and clinical supply services, has completed its relocation to its $23 million state-of-the-art facility in Bethlehem, PA.
The new Bethlehem facility was acquired by the company for $14 million in 2017 An additional $9 million was invested on refitting the facility and relocating services from its Phoenixville, PA site.
The site offers fully integrated, co-located clinical services including:
• Formulation development
• Analytical services
• Clinical manufacturing
• Packaging
• Clinical storage
• Distribution
• Interactive Response Technology (IRT)
“With the capabilities on offer at Bethlehem we provide greater capacity, scalability and automation to our clients and can simultaneously support multiple global phase III studies," said Frank Lis, president, Sharp Clinical Services. "With the Bethlehem facility, we’ve co-located our industry leading clinical services at one site—this dramatically reduces the risks, costs and supply chain complexity for our clients as we support them through development and every trial phase. Sharp has also added small-scale commercial packaging capabilities to the Bethlehem site which enables seamless scale up to commercialization for our clients.”
The Bethlehem development has 1.5 million cubic feet of clinical services capacity on a 14-acre site and increases pallet space for both cold and controlled-temperature storage by approximately 50%. Sharp says it plans to expand capacity and introduce new capabilities at the site with automated syringe assembly/labeling, automated vial labeling and automated pouch filling as part of a global equipment investment plan that will exceed $1 million.
The new Bethlehem facility was acquired by the company for $14 million in 2017 An additional $9 million was invested on refitting the facility and relocating services from its Phoenixville, PA site.
The site offers fully integrated, co-located clinical services including:
• Formulation development
• Analytical services
• Clinical manufacturing
• Packaging
• Clinical storage
• Distribution
• Interactive Response Technology (IRT)
“With the capabilities on offer at Bethlehem we provide greater capacity, scalability and automation to our clients and can simultaneously support multiple global phase III studies," said Frank Lis, president, Sharp Clinical Services. "With the Bethlehem facility, we’ve co-located our industry leading clinical services at one site—this dramatically reduces the risks, costs and supply chain complexity for our clients as we support them through development and every trial phase. Sharp has also added small-scale commercial packaging capabilities to the Bethlehem site which enables seamless scale up to commercialization for our clients.”
The Bethlehem development has 1.5 million cubic feet of clinical services capacity on a 14-acre site and increases pallet space for both cold and controlled-temperature storage by approximately 50%. Sharp says it plans to expand capacity and introduce new capabilities at the site with automated syringe assembly/labeling, automated vial labeling and automated pouch filling as part of a global equipment investment plan that will exceed $1 million.
Related Searches:
